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ABSTRACT 
The in vitro swelling action of L-thyroxine on rat liver mitochondria as examined 
photometrically represents an acceleration of a  process which the mitochondria 
are already inherently capable of undergoing spontaneously, as indicated by the 
identical  kinetic characteristics and  the extent  of  thyroxine-induced and  spon- 
taneous swelling,  the nearly identical pH  dependence, and the fact that sucrose 
has a specific inhibitory action on both types of swelling. However, thyroxine does 
not appear to be a  "catalyst" or coenzyme since it does not decrease the tem- 
perature coefficient of spontaneous swelling.  The  temperature coefficient is very 
high, approximatNy 6.0 near 20  °. 
Aging of mitochondria at 0 ° causes loss of thyroxine sensitivity which correlates 
closely with the loss of bound DPN from the mitochondria, but not with loss of 
activity of the respiratory chain or with the efficiency of oxidative phosphoryla- 
tion.  Tests with  various respiratory chain inhibitors showed  that  the oxidation 
state of bound DPN  may be a  major determinant of thyroxine sensitivity; the 
oxidation state of the other respiratory carriers does not appear to influence sensi- 
tivity  to  thyroxine.  These facts and other considerations suggest that a  bound 
form of mitochondrial DPN is the "target" of the action of thyroxine. 
The thyroxine-induced swelling is not reversed by increasing the osmolar con- 
centration of external sucrose, but can be "passively" or osmotically reversed by 
adding  the high-particle weight solute polyvinylpyrrolidone.  The mitochondrial 
membrane becomes more permeable to sucrose during the swelling reaction. On 
the other hand,  thyroxine-induced swelling can be  "actively" reversed by ATP 
in a  medium of 0.15 M KC1  or NaC1 but not in a  0.30 ~  sucrose medium.  The 
action of ATP is specific;  ADP,  Mn  +*, and ethylenediaminetetraacetate are not 
active. It is concluded that sucrose is an inhibitor of the enzymatic relationship 
between oxidative phosphorylation and the contractility and permeability proper- 
ties of the mitochondrial membrane. 
Occurrence of different types of mitochondrial swelling, the intracellular factors 
affecting the swelling and shrinking of mitochondria, as well as the physiological 
significance of thyroxine-induced swelling are discussed. 
Earlier work  in  this laboratory has shown  that 
the action of thyroxine on phosphorylating respira- 
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tion  in  liver  mitochondria  is  quite  different  in 
nature from the action of the  classical  uncoupling 
agent 2,4-dinitrophenol, with which thyroxine has 
often  been  compared.  Although  thyroxine  may 
uncouple  oxidative  phosphorylation  in  intact 
mitochondria  (1-4),  it was  found  not to uncouple 
phosphorylation  occurring  in  submitochondrial 
fragments  (5-10),  suggesting its action  is indirect 
and  dependent  on  some  aspect  of  mitochondrial 
structure.  Phosphorylation  in  submitochondrial 
fragments is, on the other hand, readily uncoupled 
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by such agents as DNP, dicumarol, and gramicidin 
(5, 10). 
A  different experimental approach  to the action 
of thyroxine was afforded by the finding that low 
concentrations  of  the  hormone  cause  very  great 
acceleration  of  the  rate  of  passive  swelling  of 
mitochondria, measured  by the optical method of 
Raaflaub  (11),  whereas  DNP  actually  prevents 
thyroxine-induced swelling (7, 9,  12).  The swelling 
action of thyroxine was  briefly remarked on inde- 
pendently  by  Klemperer  (4)  and  has  since  been 
confirmed  by  Dickens  and  Salmony  (13),  Beyer, 
Li3w, and Ernster (14) and Emmelot and Bos (15). 
That  the  in vitro swelling action  of  thyroxine  on 
isolated  mitochondria  may  be  relevant  to  the 
action of thyroxine in vivo was shown by the finding 
that  mitochondria  isolated  from  the  livers  of 
hyperthyroid rats have a much higher spontaneous 
swelling rate,  and  those  from hypothyroid  rats  a 
much  lower  swelling  rate  than  those  from  livers 
of euthyroid rats (12). 
From  such  experiments  it  was  postulated  (7, 
9)  that thyroxine  interacts with  certain  receptors 
in  the  mitochondrial  membranes  to produce  con- 
figurational  changes  in  their  molecular  organiza- 
tion. Uncoupling of phosphorylation  by thyroxine 
may therefore be a result of "dislocation" of active 
centers  of  the respiratory  or coupling enzymes in 
the  membrane  fabric.  Such  a  disturbance  in  the 
organization  of  the  membranes  could  also  be 
expected  to  produce  changes  in  the  dynamic 
steady state configuration of the mitochondrion, in 
which passive swelling is counterbalanced by active 
contraction (16, 17). Thus, in addition to producing 
changes  in  respiration  and  phosphorylation, 
thyroxine may also cause changes in permeability 
and  active binding or accumulation  of substrates, 
phosphate,  nucleotides,  and  simple  electrolytes 
(9). 
The  swelling  action  of  thyroxine  and  other 
agents on rat liver mitochondria has been surveyed 
in an earlier publication from this laboratory  (12). 
This paper presents a  more detailed study of some 
factors concerned in the thyroxine-induced swelling 
of rat liver mitochondria and its reversal by ATP. 
These  experiments  represent  an  approach  to 
identification  of  the  molecular  "targets"  in  the 
mitochondrial  structure  with  which  thyroxine 
reacts  and  also  show  that  thyroxine-induced 
swelling  is  fundamentaUy  similar  to  spontaneous 
swelling. An accompanying paper  (18)  shows  that 
red~ced  glutathione  also  causes  a  swelling  of 
mitochondria, which appears  to be quite different 
in nature from that induced by thyroxine. 
Experimental Details 
Rat liver mitochondria were isolated by the method 
of Schneider  (19),  employing 0.25  g  sucrose,  without 
added EDTA. Care was taken to avoid contamination 
by  the  nuclear  fraction,  the  microsomes,  and  the  so 
called  "fluffy layer."  The  mitochondria  were washed 
three times with cold 0.25 M sucrose  and  then gently 
suspended in 0.25 M sucrose  to make a stock suspension 
which  was  kept  at  0 °,  containing  the  mitochondria 
derived from 1.0 gm. of fresh rat liver per ml. The rats 
(Carworth Farms, Wistar) were always fed ad llbltum. 
The standard  test system for mitochondrial swelling 
experiments consisted of 5.0  ml. 0.3  ~  sucrose-0.02  M 
tris  (hydroxymethyl)-aminomethane-HC1 (tris)  buffer, 
pH 7.4, made up in 15 X  100 ram.  test tube cuvettes 
suitable  for  use  in  the  tube  holder  of  the  Beckman 
model B  spectrophotometer.  Temperature control was 
very critical  (see below)  and  tubes were incubated  in 
constant temperature water baths. Absorbancy changes 
were read at 520 m/z over specified  time intervals. The 
reaction was begun by adding mitochondria from the 
stock suspension  to the otherwise complete test medium. 
Approximately 0.05  to 0.10  ml.  of such  a  suspension 
(40  to  100  rag.  tissue equivalent)  was added  to  each 
tube,  yielding an initial absorbancy between 0.50  and 
0.70. Absorbancy of such suspensions  at 520 m# in the 
range 0.15  to 0.70  was approximately linear with the 
concentration  of  mitochondria;  all  experiments  were 
carried out in this range. It has been established  that 
the absorbancy of rat liver mitochondria in this range 
is quantitatively related, in an inverse manner, to the 
water content of the mitochondria (11, 16,  17, 20, 21). 
However it has not been established that such propor- 
tionality existed under all of the great number of differ- 
ent  experimental  conditions  employed  in  this  study. 
Theoretically, changes  in light  transmission  could  be 
caused  not  only  by  changes  in  volume of  the  mito- 
chondria,  but also by aggregation, by lysis to smaller 
particles, or by loss of refractile or absorbing material 
from the mitochondria. 
L-Thyroxine,  of high purity, made available through 
the  generosity  of  Dr.  Arthur  E.  Heming  of  Smith, 
Kline, and  French,  Inc., Philadelphia,  was used in all 
experiments and was made up in a clear stock solution 
of 1 X  10  -3 M at 30 ° with the aid of NaOH to yield a 
final pH of about 8.0. 
EXPERIMENTAL  RESULTS 
Preparative  History  of  Mitochondria  and  the 
Thyroxine Swelling E ffect.--Mitochondria  prepared 
in 0.88 ~  sucrose are relatively intact with rod-like 
morphology  (22),  but  they  are  not  highly  active 
in fatty acid oxidation and oxidative phosphoryla- LEHNINGER,  RAY, AND  SCHNEIDER  99 
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Fro.  1.  Effect of sucrose  concentration on spontaneous and  thyroxine-induced swelling.  Medium was 0.02 
tris pH 7.4 and sucrose  concentrations shown. L-Thyroxine was 1 X  10  _5 ~; temperature,  20  °. 
tion because  of the inhibitory  action of high con- 
centrations  of  sucrose  (19,  23,  24).  Such  mito- 
chondria  are relatively insensitive to  the swelling 
action of thyroxine. A procedure employing 0.44 M 
sucrose has been found to show excellent preserva- 
tion of both  morphology and  enzymatic organiza- 
tion  (25);  this  medium  was  used  in  an  earlier 
study  of  the  thyroxine-induced  swelling of  mito- 
chondria  in  this  laboratory  (12).  However  it has 
been  found  on  further  study  that  mitochondria 
prepared  in 0.25  M sucrose  (19)  are actually more 
sensitive  to  thyroxine  than  those  prepared  in 
higher  sucrose  concentrations,  even  though  they 
have already undergone some swelling and morpho- 
logical  disorganization  (19,  25-28)  and  have  a 
higher  rate  of  spontaneous  swelling  than  those 
prepared in 0.44 M or 0.88 ~  sucrose. Mitochondria 
prepared  in  0.25  M  sucrose  and  stored  in  this 
medium  at  0 °  ordinarily  gave maximum  swelling 
response  to thyroxine for several hours,  and  some 
response  could usually be detected  24 hours  after 
preparation.  Addition  of  EDTA  to  the  0.25  M 
sucrose  isolation  medium  was  found  unnecessary 
to obtain mitochondria yielding maximum swelling 
response,  contrary  to  the  finding  with  0.44  M 
sucrose (12), and it was never used. 
Mitochondria  prepared  with  media  containing 
polyvinylpyrrolidone  (PVP),  which  are  morpho- 
logically relatively intact  (26),  do not swell when 
exposed  to  thyroxine  unless  the  PVP  is  first 
removed by washing with 0.25 M sucrose. 
Effect  of  Sucrose  Concentration  in  the  Swelling 
Test Medium.--In  Fig.  1 are  shown  comparisons 
of  the  rates  of spontaneous  swelling and  thyrox- 
ine-induced  swelling  as  a  function  of  sucrose 
concentration.  The  spontaneous  swelling  rate  is 
greater  at  low  sucrose  concentration  and  ap- 
proaches  zero at sucrose concentrations  above 0.3 
to 0.4 M at 20  °, as shown earlier (11,  12). However, 
it  is  seen  that  the  thyroxine-induced  swelling  is 
similarly  dependent  on  sucrose  concentration. 
Actually  the  action  of  even very high  concentra- 
tions of L-thyroxine could be completely abolished 
as  sucrose  concentration  was  increased  substan- 
tially above 0.5 •.  It is evident that  spontaneous 
and  thyroxine-induced  swelling  are  affected  in  a 
very similar way by variations in sucrose concen- 
tration. Other experiments reported below indicate 
that  sucrose,  in  addition  to  affecting  osmotic 
relationships,  also  may have an  inhibitory  action 
on  some  enzyme  systems  concerned  in  swelling 
and its reversal. 
The  inhibition  of  the  thyroxine  swelling  effect 
by high sucrose  concentrations has  been found  to 
be  reversible if the  time of  exposure  is relatively 
short.  Mitochondria  kept  in  a  medium  of  1.0  M 
sucrose  for  30  minutes  at  20  ° ,  conditions  under 
which no swelling  whatsoever can  be induced  by 
1  X  10  -5  M  thyroxine,  and  then  re-isolated  by 
centrifugation and suspended in 0.3 M sucrose~0.02 
M tris pH  7.4,  were  found  to swell rapidly  in  the 
latter  medium  when  1  X  10  -5  M  thyroxine  was 
added. 
Effect  of  Other  Solutes  on  Thyroxine-Induced 
SweUing.--The  thyroxine-induced  swelling  of  rat 
liver  mitochondria  could  also  be  observed  in 
media  containing  glucose,  raft]nose,  KC1,  or 
NaC1  as  major  solutes.  The  behavior  of  mito- 
chondria in glucose and raffinose media is qualita- 
tively  similar  to  that  in  sucrose.  The  swelling 100  MITOCHONDRIAL  SWELLING 
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FIG. 2.  Effect of KC1 on thyroxine-induced swelling. 
The test medium was 0.15 M KC1-0.02 M tris pH 7.4. 
Temperature, 20  °  . 
behavior in isotonic KC1 was of  special  interest, 
since K  +  is  the major intraceUular cation. K +  is 
freely  and  rapidly permeable  into  mitochondria 
and  is  actively  accumulated  during  respiration 
and  phosphorylation,  presumably  in  a  bound 
form  (29-33).  Fig.  2  shows  that  rat  liver mito- 
chondria have a higher spontaneous swelling rate 
in 0.15 M KC1 than in 0.3 M sucrose. However, thy- 
roxine always caused a substantial increment in the 
rate  of  swelling.  In fact  it has  been found  that 
rat liver mitochondria in 0.15 ~  KC1 will respond 
to  significantly lower  concentrations of  thyroxine 
than  in a  medium of  0.3  M sucrose,  despite  the 
fact  that  they are already spherical and swollen. 
As is shown below,  reversal of  thyroxine-induced 
swelling  by ATP can be readily demonstrated in 
a KC1 medium, but not in a sucrose medium. 
High  molecular weight  solutes  which  are  pre- 
sumably not diffusible  through the mitochondrial 
membrane, such as serum albumin, serum T-globu- 
lin,  and  polyvinylpyrrolidone  (PVP)  (26, 27), 
inhibit  both  the  spontaneous  and  thyroxine- 
induced swelling.  As little as  1.0 rag.  per  ml. of 
crystallized  bovine  serum  albumin  completely 
prevents the  swelling  normally induced by  1  X 
10  -5  M L-thyroxine  in  0.3  M sucrose.  Similarly, 
swelling is prevented by PVP, but at higher con- 
centrations. Presumably these  solutes preserve  a 
"colloid"  osmotic  pressure  difference  across  the 
membranes  (cf.  32).  Undoubtedly  part  of  the 
effect of serum albumin is due to binding of thyrox- 
ine. 
Kinetics  and  Extent  q(  the  Swelling  Reac- 
tion.--The findings in Fig. 3 show that the sponta- 
neous  swelling of  freshly prepared  mitochondria 
in sucrose  proceeds to a  stable and characteristic 
end  value  which  represents  about  30  to  40  per 
cent of the initial optical absorbancy of the suspen- 
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FIO. 3.  Kinetics  of  spontaneous  and  thyroxine- 
induced  swelling. Standard  test  system  of  5.0  ml. 
0.3  ~  sucrose-0.02 ~  tris  pH  7.4 plus  50 mg.  tissue 
equivalent  mitochondria  at  temperatures  shown. 
L-thyroxine was added in concentration of 1.0 X  10  -5 
M. 
sion under the geometrical and optical conditions 
employed.  This  change  corresponds  to  about  a 
threefold  increase  in  volume,  or  a  reduction  in 
per  cent dry weight  to  about  10  to  12  per  cent 
(cf.  11, 32). It is also seen that the identical termi- 
nal absorbancy value is  reached  in the presence 
of  high  concentrations of  thyroxine,  but  much 
more  rapidly.  At  higher  temperatures  (37  °  ) 
swelling  in  the  presence  of  thyroxine  begins 
immediately without a  detectable lag period and 
proceeds rapidly to the same terminal value as at 
lower temperatures (Fig. 3). At lower temperatures 
a lag period is evident which is followed by a sharp 
break  into  the  normal  swelling curve.  The  lag 
period  is  also  often  evident in  the  spontaneous 
swelling (see also reference 11) and is followed  by 
a  more rapid decline to a plateau which also ulti- 
mately approximates that attained in the presence 
of thyroxine. These findings suggest that thyroxine 
hastens  a  process  which  the  mitochondria  are 
already inherently capable of undergoing sponta- 
neously, and that thyroxine-induced swelling may 
not differ  in kind from  spontaneous swelling.  On 
the other hand, swelling induced by other agents 
such  as  glutathione is  characterized  by  sharply 
different properties and kinetics and presumably 
has a  different chemical and morphological basis 
(18). 
Temperature Coefficient qf the Swelling Reaction.- 
Spontaneous and thyroxine-induced swelling have 
extraordinarily high  temperature  coefficients,  as 
is shown from the experiments in Table I. In order LEHNINGER,  RAY,  AND  SCHNEIDER  101 
TABLE  I 
Effect of Temperature  on Thyroxine-Induced 
and Spontaneous  Swelling 
Standard  test  system  of  0.3 M sucrose--0.02 M tris 
pH 7.4, plus 50 mg. tissue equivalent of rat liver mito- 
chondria and  incubations carried out at  temperatures 
noted,  with  frequent  readings  of  light  absorbancy  at 
520 mt~. Swelling rate expressed as reciprocal of "quar- 
ter-time" of swelling. 
Thyroxine-induced  swelling 
T  1/t¼  Qto 
°C 
0 
10 
15 
20 
25 
3O 
35 
min.-I 
0.013 
0.045 
0.10 
0.27 
0.50 
0.83 
1.40 
3.5 
4.8 
6.0 
5.0 
3.1 
2.8 
Spontaneous swelling 
Qt0  T  1/t[ 
o C  min.-I 
10  0. 0045 
20  0. 022 
30  0. 066 
40  0.250 
4.8 
3.0 
3.8 
to  use  the  kinetic  data  on  rates  of  swelling  for 
calculation  of  temperature  coefficients  (Qao) and 
the  energies  of  activation,  the  initial  rates  were 
taken  as  the  time  required  to  reach  one-fourth 
the  maximal  extent  of  swelling as  determined  by 
absorbancy  measurements  (so  called  "quarter- 
times,"  tl/4).  The  calculated  temperature  coeffi- 
cients  (Qt0)  are  given  for  adjacent  temperature 
intervals.  It  is  seen  that  Qt0  at  all  temperature 
ranges tested, for both spontaneous and thyroxine- 
induced  swelling,  is  higher  than  that  of  most 
chemical and enzymatic reactions and much higher 
than  for a  simple  diffusion  process.  An apparent 
energy of activation for thyroxine-induced swelling 
may be calculated from the Arrhenius equation. For 
the  interval  15°-20  °  it is some 33,400  calories per 
"mole."  It  is  pertinent  that  a  number  of  mem- 
brane-dependent  phenomena  are  known  to  have 
high temperature  coefficients. A  recent example is 
provided by the studies of Crane el al. on the rate 
of penetration of sugars into Ehrlich ascites tumor 
cells (34),  which  shows Q10 values of about  4.0 at 
20  °" 
These  findings  indicate  that  thyroxine  is  not 
acting as a  catalyst in  the ordinary sense  (i.e.,  by 
lowering the activation energy of the spontaneous 
swelling process),  since if anything,  the Q10 of the 
thyroxine-induced swelling is somewhat larger than 
that of spontaneous swelling. However the process 
measured  by  the  aborbancy  changes  is  un- 
doubtedly  very  complex  and  as  yet  difficult  to 
interpret precisely. 
Inadequate  recognition  of  the  very  critical 
dependence  of  swelling rate  on  temperature  may 
account for some fluctuations in behavior noted in 
earlier  work  and  some  discrepancies  between 
findings in different laboratories. 
Effect  of pH.--The  swelling effect of  thyroxine 
is strikingly dependent on pH, as is shown in Fig. 
4.  The  increment  in  swelling  rate  produced  by 
thyroxine  is maximum  at pH  7.5  in  a  medium  of 
0.3  M sucrose  buffered  with  0.02  M  tris-histidine 
mixtures.  The  thyroxine  effect  is  completely 
absent  above  pH  8.5,  is  still  pronounced  at  pH 
7.0,  but absent  at pH 6.5.  In  this  experiment  the 
thyroxine-induced  swelling was  measured  at  20  °, 
at  which  the  rate  of  spontaneous  swelling  was 
insignificant. The spontaneous  swelling was meas- 
ured at 30  ° at which it proceeds at an appreciable 
rate,  and  was  found  to  have  approximately  the 
same  pH  dependence  (cf.  reference  11)  as  the 
thyroxine-induced  swelling, again suggesting simi- 
larity  of  the  mechanism  of  spontaneous  and 
thyroxine-induced  swelling.  The  optimum  pH  for 
glutathione-induced swelling is substantially differ- 
ent (18). 
Sensitivity  of  Mitochondria  to  Thyroxine.-- 
Earlier  experiments  showed  measurable  swelling 
responses with about  10  -6 i  thyroxine (12), which 
Fie. 4.  Effect of pH on thyroxine-induced and spon- 
taneous  swelling  of  rat  liver mitochondria.  Standard 
test  system  contained  0.3  M sucrose,  0.02  M tris,  and 
0.02  M histidine,  brought  to  the pH values shown; 50 
mg.  tissue  equivalent  rat  liver  mitochondria  were 
added.  Thyroxine was added  at  l  X  10  -5 M and  the 
rate  of  swelling  at  20  °  observed.  The  spontaneous 
swelling rate was measured at 30  °  . 102  MITOCHONDRIAL  SWELLING 
is about 100 times the concentration of "thyroxine" 
in the blood and tissues of euthyroid animals, but 
considerably  lower  than  that  usually  required 
(>2  X  10  -5 M)  to uncouple phosphorylation from 
respiration  in  in  vitro  experiments  with  mito- 
chondria  (1-4,  8).  On  closer  study,  using  the 
standard  test system  of  0.3  M sucrose-0.02  M tris 
buffer  pH  7.4,  and  temperatures  of  200-25  °, 
thyroxine  was  often  found  to  cause  significant 
increases in the rate of swelling at concentrations 
of  1  >(  10  -7  ~  and  occasionally  at  1  ×  10  -8  M. 
However,  as  mentioned  above,  mitochondria  are 
consistently  more  sensitive  to  thyroxine  in  a 
medium  of  0.15  M KC1;  response  to  1  ×  10  -s  M 
thyroxine  was  often  seen.  The  sensitivity of  rat 
liver  mitochondria  to  thyroxine-induced  swelling 
can  be  expected  to  be  greater  at  temperatures 
approaching  37  ° .  Physiological  concentrations  of 
thyroxine thus are capable of producing detectable 
mitochondrial swelling. 
Effect  of  Aging  of  Mitochondria.--Sensitivity 
of  mitochondria  to  thyroxine-induced  swelling  is 
lost on aging at 0 °. Experiments were carried out 
to  determine  to  what  extent  loss  of  thyroxine- 
sensitivity  correlated  with  some  characteristic 
degenerative  changes  in  the  mitochondria  meas- 
ured  by  enzymatic  tests.  In  experiments  sum- 
marized in Fig.  5  samples were  taken at different 
time  intervals  from  a  stock  suspension  of  mito- 
chondria held  at  0 °  (1  ml.  =  1 gm.  equivalent). 
Measurements  were  then made  of  the  thyroxine- 
induced  swelling  rate  in  a  standard  test medium 
of 0.3 ~t sucrose-0.02 ~  tris pH  7.4.  At  the  same 
time  intervals,  samples  of  the  stock  suspension 
were  tested  for  the  rate  of  oxidation  of  I)-/3-hy- 
droxybutyrate and the P:2e ratio of the oxidative 
phosphorylation  linked  to  this  oxidation  in  the 
absence of added DPN, as well as the rate of oxida- 
tion  of  n-/3-hydroxybutyrate  in  the  presence  of 
added  DPN. 
It  is  seen  from  the  curves  that  the  thyroxine- 
induced swelling of the mitochondria in  the stand- 
ard test system was maxima! during about 6 hours 
of  storage  of  the  stock  suspension at  0 °,  but  fell 
off sharply thereafter; only one-fourth the original 
sensitivity remained  at  24  hours.  Over  the  same 
time  interval  the  rate  of  oxidation  of  D43- 
hydroxybutyrate  by  the  mitochondria  in  the 
absence of added DPN, which is a  test of the con- 
tent of bound DPN  (48), also remained maximum 
for about 6 to 9 hours of aging and then decreased 
markedly.  On the other hand, when the oxidative 
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FIG. 5.  Relationship  of  bound  DPN  to  thyroxine- 
sensitivity.  Freshly  prepared  mitochondria were  sus- 
pended in 0.25 ~t sucrose (1 ml. contained 1 gm. tissue 
equivalent), and held at 0 °. At different time intervals 
samples  were  removed  and  tested  in  the  following 
systems: 
a.  Thyroxine-Induced  Swelling.--Standard  test  sys- 
tem of 0.3 M sucrose-0.02 M tris pH  7.4 at 20  °, in ab- 
sence and presence of  1  X  10  -5  M L-thyroxine.  The 
reaction was started by adding 0.05 ml. mitochondria. 
The  sensitivity  to  thyroxine  recorded  is  arbitrarily 
designated as the optical density increment at 520 m# 
produced  by  thyroxine above the control swelling, in 
absence  of  thyroxine,  observed  at  the  5.0  minute 
interval. 
b.  Oxidation via "Bound" DPN.--The mitochondrial 
sample,  taken  from  the  stock  suspension undergoing 
aging, and equivalent to 300 mg. fresh liver, was added 
at zero time to a  test system containing 0.02 M nL-~- 
hydroxybutyrate,  0.0024  M ADP,  0.025  ~  phosphate 
labelled  with  p3~, 0.005  u  MgCI2,  0.001  M  EDTA, 
0.025  M  glucose,  and  5.0  mg.  purified  hexokinase 
(Sigma).  The reaction was  stopped,  after  20 minutes 
incubation  at  20  °,  with  trichloroacetic  acid  and  the 
acetoacetate  formed  and  phosphate  taken  up  deter- 
mined as described previously  (11).  Rate of oxidation 
given in terms of/zmoles acetoacetate formed in above 
test system in 20 minutes. 
c.  Efficiency  of  Oxidative  Phosphorylatlon.--The 
P:2e ratios were calculated from data collected under 
(b). 
d.  Oxidation in Presence of Excess DPN.--The basic 
test system described under (b) was supplemented with 
0.003 ~  DPN and the rate of oxidation expressed in the 
same terms. 
test  system  was  supplemented  with  "external" 
DPN,  the  rate of oxidation of D-/3-hydroxybutyr- 
ate  remained  high  and  constant  over  a  50-hour 
period  of  aging  of  the  mitochondria  at  0 °.  The 
efficiency of  oxidative phosphorylation,  expressed 
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DPN remained nearly maximal and did not start 
to  decline until about  30  hours  of  aging at  0  °, 
despite the already significant drop in the bound 
DPN  and  consequent decline in  oxidation rate. 
Loss  of  sensitivity to  thyroxine  thus  correlates 
very well with the loss of bound, functional DPN 
during aging of  the mitochondria at 0  °, but does 
not  correlate  well  with  the  relatively  constant 
efficiency  of  oxidative  phosphorylation  and  the 
constant rate  of  oxidation when  excess  DPN  is 
added. These findings with thyroxine are therefore 
consistent with  those  of  Hunter and  Ford  (35), 
who  have  shown  that  swelling of  mitochondria 
induced  by  inorganic phosphate  is  concomitant 
with loss or destruction of bound pyridine nucleo- 
tides. This similarity was confirmed by our finding 
that phosphate-treated mitochondria do not swell 
further  in  the  presence  of  thyroxine. 
These findings and others to be enumerated be- 
low suggest that mitochondrial DPN may be in- 
volved in the action of thyroxine. However, it is 
also  known that  spontaneous swelling  is  accom- 
panied by destruction of intramitochondrial ATP 
(17,  36). 
Effect  of Respiratory  Inhibitors  on  the  Suscepti- 
bility  of Mitochondria  to Thyroxine-Induced  Swell- 
ing.--The  action of the respiratory carriers, which 
are  embedded  in  the  membranes and/or  cristae 
(37-39),  appears  to  be  a  determinant of  the  re- 
sponsiveness of  the mitochondria to  the  swelling 
FIG. 6.  Action of antimycin A and amytal on thy- 
roxine-induced swelling. Standard  test  system  of 5.0 
ml. 0.3 ~ sucrose-0.02 ~ tris pH 7.4 at 20  °. Thyroxine 
was added at 1 X 10  -5 M. Antimycin A added as freshly 
prepared solution in 50 per cent ethanol, yielding final 
concentration of 0.12 micrograms antimycin A per ml. 
Sodium amytal was added as a freshly prepared 0.18 
solution in 50 per cent ethanol, yielding a final concen- 
tration of 0.0018 •  sodium amytal and 0.5 per  cent 
ethanol.  Antimycin and amytal tubes also contained 
O.00l  M D-/~-hydroxybutyrate to  ensure reduction  of 
carriers  to point of inhibition. All tubes contained 50 
mg. tissue equivalent of rat liver mitochondria, added 
last. 
action  of  thyroxine.  Lehninger  and  Ray  (40) 
have demonstrated that thyroxine does not cause 
swelling of rat liver mitochondria in the presence 
of  cyanide  or  under  anaerobic  conditions; such 
conditions also prevent the action of other swelling 
agents  (40,  41).  It  was  suggested  that  swelling 
induced by thyroxine and other  agents does  not 
occur  when  the  respiratory  carriers  are  main- 
tained in the reduced state  (40).  Experiments in 
Fig.  6  show  that  thyroxine-induced swelling  is 
also  prevented  in  the  presence  of  excess  ¢Lhy- 
droxybutyrate as  chain reductant, by antimycin 
A, which blocks respiration between cytochromes 
b and c  (42) and also by sodium amytal, which 
blocks  respiration between DPN and flavoprotein 
(42,  43).  The mitochondrial DPN  is  in the fully 
reduced form in the presence of each of the three 
respiratory inhibitors when substrate is in excess, 
whereas the oxidation-reduction state of the other 
carriers  varies  depending on  the  inhibitor used. 
These  circumstances are  consistent with  the  hy- 
pothesis that bound DPN is the site of action of 
thyroxine and that the mitochondria are susceptible 
to  thyroxine-induced swelling only when at least 
some  of  the  DPN  is  in  the  oxidized  state;  the 
oxidation-reduction  state  of  the  other  carriers 
appears to be irrelevant to the action of thyroxine. 
An  alternative explanation is  that  thyroxine- 
induced or spontaneous swelling can occur only if 
respiration is proceeding so  that any respiratory 
inhibitor, regardless  of site of action, would result 
in prevention of swelling (44). However, other ob- 
servations on the relation of respiration to swelling 
and its reversal (16, 17) are not all easily explained 
on this basis, nor are the findings on glutathione- 
induced swelling (18).  Whatever the basis for in- 
hibition of  swelling by  agents  which  block  the 
respiratory chain, it  is  clear  that  the  oxidation- 
reduction  state  of  the  respiratory  carriers  other 
than  DPN  is  not  a  factor  in  sensitivity  to 
thyroxine-induced swelling. 
"Passive"  or  Osmotic  Reversal  of  Thyroxine- 
Induced  Swelling.--Experiments  were  carried out 
to  determine whether  thyroxine-induced swelling 
could be reversed by introduction of high concen- 
trations of solutes such as sucrose, serum albumin, 
and PVP into the test medium in order to increase 
the  extramitochondrial  osmotic  pressure.  When 
thyroxine-induced swelling  was  first  allowed  to 
take place in the normal medium of 0.3 ~t sucrose 
and an addition of  concentrated sucrose  solution 
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Fio. 7.  Effects  of  hypertonic  sucrose  and  PVP  in 
reversal of swelling.  Tests carried  out at  20  ° and  pH 
7.4. Top curve (in left figure) shows that 0.87 I  sucrose 
completely prevents swelling  induced  by  i  X  10  -5 M 
thyroxine.  The  bottom  curve  (triangles)  shows  the 
usual  swelling produced  by  1  X  10  -a M thyroxine  in 
0.3  N sucrose  medium.  At 5 minutes,  sucrose  concen- 
tration in duplicate tube was raised to 0.87 M; the dotted 
line shows  that  delayed  addition  neither  stopped  nor 
reversed the thyroxine-induced swelling. 
In experiments shown in right figure,  effect of PVP 
(7.7  per cent final  concentration,  in standard  sucrose- 
tris medium)  on  swelling  is shown.  Top  curve shows 
prevention of swelling induced by 1 X  10  -a M thyroxine 
by  PVP  added  at  zero  time.  Curve labelled T4  (tri- 
angles)  shows  normal  swelling,  in  absence  of  PVP. 
When PVP was added to duplicate tube at 10 minutes 
after  T4-induced  swelling  began,  the  absorbancy  in- 
creased as shown in dotted line. 
to  0.87  M  (a  concentration  which  can  prevent 
thyroxine-induced  swelling  when  added  initially 
(see Fig.  1)), itwas found, as shown in Fig. 7, that 
such a  delayed addition of a  high sucrose concen- 
tration  after swelling  had  begun  had  absolutely 
no  retarding  or  reversing  effect  on  the  swelling. 
From such  experiments  it may be concluded  that 
the permeability  of  the  mitochondrial  membrane 
(s)  to  sucrose  has  undergone  a  change  following 
thyroxine-induced swelling, so that sucrose perme- 
ates  more  readily  following swelling,  allowing no 
significant osmotic pressure  gradient  to  be  set up 
by increasing external sucrose concentration. Also, 
it appears  probable  that  a  small amount of swell- 
ing must  first occur before thyroxine can become 
effective in  altering  the  permeability  to  sucrose, 
otherwise  it  could  be  expected  that  thyroxine 
would  cause  an  immediate  swelling  even  in  the 
presence of 0.87 M sucrose. The definite lag period 
(Fig. 3) supports  this explanation. 
On  the  other  hand,  it  was  possible  to  reverse 
thyroxine-induced  mitochondrial  swelling  almost 
completely by addition of a  solute of much higher 
particle  weight,  namely  polyvinylpyrrolidone 
(particle weight 60,000  to 70,000).  Experiments in 
Fig.  7  show  that  PVP  not  only  completely pre- 
vents  swelling by  thyroxine  but  also  can  reverse 
it  almost  completely  after  it  has  nearly  reached 
the terminal absorbancy plateau. Although perme- 
ability to sucrose has increased strikingly following 
thyroxine-induced  swelling,  the  mitochondrial 
membranes apparently remain relatively imperme- 
able  to  PVP  and  thus  permit  maintenance  of  a 
high osmotic pressure gradient when PVP is added 
to  the  medium. 
"Active"  Reversal of  Thyroxine-Induced  Swell- 
ing.--Although  Dickens  and  Salmony  (13)  have 
reported the reversal of thyroxine-induced swelling 
by  simple addition  of ATP  to  a  sucrose  test me- 
dium  similar  to  that  used  in  this  study,  in  our 
hands ATP or the combination of ATP and Mg  ++ 
(or Mn  4+) did not prove to be capable of reversing 
the swelling action of thyroxine on rat liver mito- 
chondria in the sucrose system. A  variety of ATP 
and  thyroxine samples were employed; also, ATP 
was added at different points in the swelling curve. 
Mitochondria  from  Sprague-Dawley,  Wistar, 
and  mongrel white rats  were  tested,  without  any 
difference  in  action.  This  failure  suggested  that 
reversal  of  thyroxine-induced  swelling  by  ATP 
is dependent  on  factors  not yet fully understood. 
On further investigation it was found that when 
a  medium  of 0.15  M-0.02  ~t tris pH  7.4 was  used 
instead  of the standard  0.3 •  sucrose-0.02  M tris, 
then  reversal  of  thyroxine-induced  swelling  by 
ATP could be readily and  reproducibly  observed, 
FIo. 8.  Reversal  of  thyroxine-induced  swelling  by 
ATP in  KC1  medium.  Thyroxine  (i  X  10  -5 ~)  was 
added  at  zero  time  to  tubes  containing  medium  of 
0.30 M sucrose--0.02 ~  tris pH 7.4 or 0.15 ~t KC1-0.02 
tris  pH  7.4  as  shown;  0.02  M sucrose  was  added  to 
0.15  ~  KC1-0.02  ~  tris  medium  as  shown.  At  time 
shown,  0.003  ~  ATP  (or  0.003  ~  ADP  or  0.001 
EDTA) was added in small volume to each tube. Data 
normalized for volume changes.  Temperature, 20  ° . LEHNINGER,  RAY,  AND  SCHNEIDER  105 
as is shown  by the experiments in Fig. 8,  which 
compare  the  effect  of  ATP  in  sucrose  and  KC1 
media.  When  sucrose  was  added  to  the  KC1 
medium, the reversing effect of ATP was inhibited. 
Further experiments showed that neither EDTA 
nor ADP  were able to  replace ATP  in reversing 
thyroxine-induced swelling, indicating  that  ATP 
is  acting  specifically,  possibly  as  a  phosphate 
donor, rather than as a non-specific metal chelating 
agent.  Neither  Mn  ++  nor  Mg  ++  could  reverse 
swelling added  alone,  nor  did  they  improve  the 
reversal  by  ATP. 
There appears to be no specific requirement for 
high  concentrations of K +  per se  in  the  reversal 
of swelling by ATP,  since reversal also occurred 
readily in  a  medium  of 0.15  xt NaC1-0.02  ~  tris 
pH  7.4. 
DISCUSSION 
Existence  of Different  Types and Stages of Milo- 
chondrial Swelling.--It is dear that mitochondria 
may undergo different types and stages of swelling, 
depending on  their initial chemical and  morpho- 
logical condition and  the nature  of  the  chemical 
stimulus,  and  it  is  probable  that  these  various 
modalities of swelling result in different morpho- 
logical configurations. Thyroxine-induced swelling 
is very similar in  a  number  of characteristics to 
the spontaneous  swelling process, but appears  to 
be quite different from swelling induced by gluta- 
thione and  cysteine (18)  and  also from  that pro- 
duced  by  p-chloromercuribenzoate  (unpublished 
observations). Also to be distingushed is the simple 
osmotic swelling in response  to  variations in  the 
external  osmotic  pressure  which  occurs  almost 
instantaneously  following  exposure  to  osmotic 
gradients, such as has been described by Tedeschi 
and  Harris  (21).  Simple  osmotic  swelling  and 
shrinking  take place in  the first seconds or min- 
utes of exposure (2l) and precede and fuse into the 
slower, presumably non-osmotic phase of swelling 
as  observed  in  photometric experiments such  as 
those  described here  (of. reference  21)  Further- 
more  it  must  be pointed  out  that  thyroxine-in- 
duced swelling may be observed in mitochondria 
that are already swollen and in which disorganiza- 
tion of the cristae is evident, as in mitochondria 
prepared in 0.25  M sucrose (25-28). On the other 
hand,  mitochondria which have undergone swell- 
ing in the presence of phosphate, do not respond 
further  in  the presence of thyroxine, presumably 
because they have already lost DPN  (35),  which 
experiments described  in  this  paper indicate  to 
be the sensitive component with  which  thyroxine 
may  interact. 
The  existence of different  types and  stages of 
mitochondrial  swelling  is  also  indicated  by  the 
fact  that  different  contraction  or  shrinking  re- 
sponses  may  be  observed,  following addition  of 
"active"  agents  such  as  ATP,  or  by  increasing 
osmotic pressure of the external medium  through 
introduction of solute molecules of differing par- 
ticle  weight.  Thus  thyroxine-induced  swelling 
can be reversed with ATP in a saline medium, but 
glutathione-induced swelling cannot (18). Thyrox- 
ine-induced  swelling can  be  reversed  osmotically 
by PVP but not by sucrose, whereas neither solute 
can  reverse  glutathione-induced  swelling  (18). 
The  complex  structure  of  the  mitochondrion, 
with its outer and inner membranes and the char- 
acteristic  arrangement  of  cristae  (45)  could  ob- 
viously permit different types and stages of mito- 
chondrial swelling to  occur,  particularly if  there 
is internal compartmentation of the mitochondrion 
and  if  the  permeability of  the  outer  and  inner 
membranes  may  differ.  The  membranes  contain 
the  enzymes  of  electron  transport  and  coupled 
phosphorylation  in  ordered  arrangement  and  it 
now  appears probable that  the permeability and 
contractility of .the membranes is conditioned by 
the activity of these enzyme systems  (9,  i1,  16). 
Since  respiration  and  phosphorylation  are  very 
complex  and  have  a  number  of  control  points 
(cf.  reference  46),  a  variety  of  chemical  and 
morphological responses can be expected when the 
mitochondria  are  exposed  to  different  agents. 
Any attempt  to  analyze in  morphological and 
physical  terms  the  swelling  action  of  thyroxine 
on  mitochondria  must  be  qualified  by  the  fact 
that many of the swelling experiments have been 
carried  out  with  already  swollen  mitochondria 
placed  in  an  unphysiological medium  containing 
a  solute,  sucrose,  which  is  in  all probability in- 
hibitory and  unfavorable,  as pointed  out  below. 
Furthermore,  the  recent  work  of  Amoore  and 
Bartley indicates that mitochondria as ordinarily 
prepared  contain  at  least  two  general  types  of 
structure, the aqueous phases of which are differ- 
ently penetrated by sucrose, KCI, and phosphate 
(47).  This fact provides little assurance of a mito- 
chondrial population which  is homogeneous  with 
respect to compartmentation and permeability. 
Nevertheless  it  appears  possible  to  correlate 
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Tedeschi  and  Harris  (21)  and  of  Bartley  and 
his  colleagues  (32,  47).  The  studies  of  Tedeschi 
and  Harris  indicate  the  mitochondrion  to  be 
surrounded  by  a  semipermeable  membrane  and 
that  the  mitochondria,  over  very short  time  in- 
tervals,  behave  as  ideal  osmometers  if  a  lane 
"osmotic dead space" of some 40  to  50 per cent 
of  the  mitochondrial  volume  is  assumed  (21). 
Werkheiser  and  Bartley  have  found,  however, 
that  mitochondria  isolated  from  0.25  M sucrose 
are  already  about  60  per  cent  penetrated  by 
sucrose, and this value is constant enough to sug- 
gest  the  occurrence  of  an  internal  compartment 
which is not readily penetrated by sucrose at 0  ° 
and  an outer  compartment which is readily pen- 
etrated  (32).  On  longer exposure to sucrose solu- 
tions  at  higher  temperatures,  more  nearly  ap- 
proximating those  used  in  this  study,  sucrose  is 
able  to  penetrate  the  inner  space  (31,  32,  47). 
From  these  considerations  it  may  be  suggested 
that the early, rapid, purely osmotic changes ob- 
served by Tedeschi and  Harris may involve  tem- 
porary osmotic  gradients across  the  inner  mem- 
brane and the slower phase of swelling, in which the 
inner  space  is  penetrated  by  sucrose,  may  be 
equivalent to  the changes studied in  the  type of 
experiment carried out in this study. Furthermore, 
it may be suggested that the permeability of the 
inner  membrane  to  sucrose  may  be  increased 
during  swelling,  particularly in  the  presence  of 
thyroxine, since high osmotic gradients of sucrose 
will  not  reverse  thyroxine-induced  swelling  al- 
though  large solute molecules such  as PVP  will. 
The reversal of swelling by ATP may be the result 
of  a  contractile process  as  has  been  postulated 
(11,  16),  possibly with restoration of the relative 
impermeability of the inner membrane to sucrose. 
This  picture  of  the  swelling process  suggests 
that  the  outer  membrane  is  of  less  significance 
than  the  inner membrane  and  is consistent with 
the view of Palade that an inner compartment and  " 
the cristae are formed by invagination of the inner 
membrane and that the respiratory enzymes may 
be  largely present  in  the  inner  membrane,  par- 
ticularly the cristae (45). 
Sucrose  as  Suspending  Medium.--The  finding 
that sucrose can inhibit swelling and also inhibits 
the reversal of swelling by ATP may be the con- 
sequence of the inhibition by sucrose of some inter- 
mediate reaction in  the  coupling of phosphoryla- 
tion to electron transport and thus the contractility 
of the mitochondrial membrane, in which respira- 
tion and phosphorylation occur. Earlier work has 
already demonstrated that sucrose inhibits respira- 
tion  (24),  uncouples  oxidative  phosphorylation 
(5), inhibits the ATP-Pi  3~ exchange reaction, and 
also the ATPase  activity in  subfragments of the 
mitochondrial  membranes  (48).  The  site  of  in- 
hibition of sucrose in the coupling mechanism has 
been tentatively identified as being on a  reaction 
between  the  terminal  transphosphorylation  (49) 
and the site of DNP action, presumably the point 
where inorganic phosphate is taken up (46). These 
findings suggest  that  the  apparent  suitability of 
sucrose for isolation of mitochondria with preserva- 
tion  of  their  morphology  is  not  primarily  oc- 
casioned by its osmotic effects, but is the result of 
a reversible inhibition or "fixation" of an enzymic 
step in the coupling of respiration with membrane 
contractility and permeability. On the other hand, 
it is quite evident that sucrose is an unfavorable 
medium for studies of mitochondrial swelling and 
its reversal. 
Site of Action of Thyroxine.--A  number of con- 
siderations point to a bound form of mitochondrial 
DPN  as the site of action of thyroxine in causing 
swelling. These may be enumerated: (1) Sensitivity 
of liver mitochondria to thyroxine-induced swelling 
correlates closely with their content of functional 
DPN,  as shown in the aging experiment (Fig. 5). 
This correlation is closer than  the correlation be- 
tween  spontaneous  swelling  and  intramitochon- 
drial ATP  (36), which falls to one-fifth its normal 
value  before  spontaneous  swelling ensues.  There 
is also no correlation with oxidative phosphoryla- 
tion.  (2)  Phosphate-treated  mitochondria,  which 
have lost DPN  (35), no longer respond to thyrox- 
ine.  (3)  Bound  DPN  is  lost  from  thyroxine- 
treated mitochondria (15), a finding which we have 
confirmed in  unpublished  experiments.  (4)  PVP, 
ATP, and Mg  ~-, which prevent thyroxine-induced 
swelling, also prevent loss of bound DPN  in  the 
presence of thyroxine (15). (5) Conditions in which 
mitochondrial DPN is in the reduced state prevent 
the .swelling action of thyroxine, whereas  the ox- 
idation-reduction  state  of  the  other  respiratory 
carriers  appears  to  be  irrelevant.  (6)  Thyroxine 
and  related  thyroactive  compounds  are  capable 
of inhibiting a  number  of DPN-linked  dehydro- 
genases  (50). 
It has  been postulated that  specifically bound 
forms of certain respiratory carriers are involved 
in  the  coupling  of  phosphorylation  to  electron 
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DPN reactive in phosphorylating respiration with 
D-/3-hydroxybutyric  dehydrogenase  appears  to 
be  present  in  phosphorylating  submitochondrial 
fragments (51). Recently Purvis has demonstrated 
the  occurrence of a  "masked"  or bound  form  of 
DPN  in intact liver mitochondria, believed to be 
concerned  in  oxidative  phosphorylation  (52). 
A functional connection between a bound form of 
DPN  and  the  condition  of  the  mitochondrial 
membrane thus appears very likely. 
Displacement or alteration of a  bound form of 
DPN  in the mitochondrial membrane by thyrox- 
ine may not suffice  to explain massive uncoupling 
of oxidative phosphorylation at all three  sites in 
the chain by very high and possibly toxic doses or 
concentrations of thyroxine (1,  2). It must be re- 
called, however,  that  mitochondria isolated from 
livers of animals made hyperthyroid by minimal 
doses  of  thyroxine  do  not  always  show  lowered 
P:O  ratios; however  such  mitochondria do show 
deficiency  in  respiratory  control  by  ADP  (3). 
The  effect of thyroxine-induced swelling of mito- 
chondria on respiratory control by ADP  is being 
investigated further. 
The Intracellular Environment and Mitochondrial 
Swelling.--Mitochondrial  swelling is  readily pro- 
moted by inorganic phosphate,  reduced glutathi- 
one,  Ca  ++ , and  thyroxine and its analogs in con- 
centrations in which they are present in the cell. 
On the other hand, the swelling induced by these 
agents,  thyroxine  included,  can  be prevented  or 
opposed by ATP, Mg  ++, Mn  ++, and probably also 
the  soluble  cytoplasmic proteins~  which  may  be 
presumed to behave like serum albumin and PVP. 
Actually the known intracellular factors opposing 
swelling appear to be ample to prevent completely 
the  swelling caused  by  the  intracellular concen- 
trations  of  the  known  swelling agents.  Although 
liver mitochondria were  often  observed  to  swell 
in vitro  in the presence of  1  X  10  -8 ~  thyroxine, 
approximately the  tyroxine concentration  in  the 
cell, this concentration, or even much higher con- 
centrations  of  thyroxine  would  cause  no  overt 
swelling if mitochondria were placed in a medium 
resembling the  intracellular fluid with respect to 
concentrations  of protein,  ATP,  and  Mg  ++.  For 
this reason it appears necessary to postulate that 
the  intracellular swelling and  contractile factors 
are normally in a  state of dynamic balance, with 
frank swelling appearing only in case of outright 
or long maintained unbalance of these factors. 
Physiological  Significance  of Thyroxine-Induced 
Swelling.--The  swelling  of  liver  mitochondria 
induced by  thyroxine in vitro  has  in vivo  signifi- 
cance, since (a)  mitochondria isolated from livers 
of  hypo-  and  hyperthyroid  rats  differ  in  the 
expected  directions  with  respect  to  the  rate  of 
spontaneous  swelling  in  sucrose  solutions  (12), 
(b)  microscopic examination  of  liver  sections  of 
hyperthyroid rats  shows  the  mitochondria  to  be 
swollen  (53),  and  (c)  electron  micrographs  of 
hyperthyroid rat liver mitochondria show disorgan- 
ization of fine structure  (54). 
Although  mitochondrial  swelling  induced  by 
thyroxine thus occurs in vivo, it is probably not a 
general  consequence  of  the  action  of  thyroxine 
on  mitochondria of all cell types. Although liver 
and  kidney  mitochondria  swell  in  response  to 
thyroxine,  those  of  skeletal and  cardiac muscle 
show  little  or  no  response  and  those  of  spleen, 
brain,  and  testis none  (55).  However  respiration 
of  skeletal  and  cardiac  muscle  is  increased  in 
hyperthyroidism and  uncoupling of phosphoryla- 
tion  in  heart  mitochondria  is  brought  about  by 
thyroxine either in vitro or in vivo (56-58). Swelling 
of mitochondria is therefore not a  necessary first 
stage  in  the  uncoupling  of  phosphorylation.  It 
is conceivable and likely, however, that thyroxine 
interacts with the same general type of chemical 
receptors or "targets" in heart mitochondria as in 
liver mitochondria, to produce changes in the re- 
lationship  of  the  respiratory  chain  enzymes  to 
the  ultrastructure  and  properties  of  the  mito- 
chondrial  membrane,  which  are  not  necessarily 
detectable  optically  as  swelling,  but  which  can 
lead to significant alteration of rates of respiration 
and phosphorylation, as well as changes in perme- 
ability  or  contractility  of  the  membranes  or 
changes in function of the active transport systems 
in these bodies. However, the characteristic action 
of thyroxine in vivo must also be dictated by organ 
distribution and  intracellular distribution of  the 
hormone. The importance of this factor is shown by 
the fact that phloridzin mimics the swelling action 
of thyroxine in all respects when tested in vitro (59), 
but the symptoms following phloridzin administra- 
tion to an intact animal are of course very differ- 
ent  from  those  of hyperthyroidism. 
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